| Title |
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
|
|---|---|
| Published in |
bioRxiv, August 2021
|
| DOI | 10.1101/2021.08.22.457114 |
| Authors |
Yafei Liu, Noriko Arase, Jun-ichi Kishikawa, Mika Hirose, Songling Li, Asa Tada, Sumiko Matsuoka, Akemi Arakawa, Kanako Akamatsu, Chikako Ono, Hui Jin, Kazuki Kishida, Wataru Nakai, Masako Kohyama, Atsushi Nakagawa, Yoshiaki Yamagishi, Hironori Nakagami, Atsushi Kumanogoh, Yoshiharu Matsuura, Daron M. Standley, Takayuki Kato, Masato Okada, Manabu Fujimoto, Hisashi Arase |
X Demographics
The data shown below were collected from the profiles of 18,443 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1909 | 10% |
| United States | 1375 | 7% |
| France | 668 | 4% |
| Canada | 331 | 2% |
| United Kingdom | 309 | 2% |
| Spain | 168 | <1% |
| Australia | 118 | <1% |
| Italy | 115 | <1% |
| Brazil | 115 | <1% |
| Other | 1149 | 6% |
| Unknown | 12186 | 66% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17770 | 96% |
| Scientists | 282 | 2% |
| Practitioners (doctors, other healthcare professionals) | 234 | 1% |
| Science communicators (journalists, bloggers, editors) | 111 | <1% |
| Unknown | 46 | <1% |